Archive for 'Tag Archives: 'Osteonecrosis''
Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials
Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]
Arthritis Awards Biomarkers biomaterial Biotechnology BioWin Cancer Cancer Therapy cancer treatment cardiology Cell therapy Clinical Studies Clinical Trials CNS Data & Statistics Diabetes Disease DNA Genetics Gosselies heart failure Imaging Immunology in-vitro inflammation Investments & Funding joint disorders Laboratory Nuclear Medicine Obesity oncology osteoarthritis Osteonecrosis Partnering spin-off stem cell UCB UCL UCL spin-off ULB ULg UMons Updates vaccines Wallonia
